TFO
TXMD icon

Tarbox Family Office’s TherapeuticsMD TXMD Stock Holding History

Tarbox Family Office’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$4K – 1184
2021
Q3 		$4K Sell
100
-40
-29% -$1.77K ﹤0.01% 733
2021
Q2 		$8K Buy
+140
New +$8.48K ﹤0.01% 535

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tarbox Family Office's TXMD Position: Q4 2021 in Review

Tarbox Family Office sold out of TherapeuticsMD (TXMD) in Q4 2021, closing a stake of 100 shares — an estimated $4K sold.

Tarbox Family Office first reported a position in TXMD in Q2 2021 and held it in 2 quarters. The position peaked at $8K in Q2 2021. 131 funds tracked by Wall St. Rank hold TXMD as of Q4 2021.

  • Tarbox Family Office reported no remaining TherapeuticsMD position as of Q4 2021 after selling out during the quarter.
  • Tarbox Family Office sold 100 TherapeuticsMD shares in Q4 2021, an estimated $4K.
  • Tarbox Family Office first reported a position in TherapeuticsMD in Q2 2021 and held it in 2 quarters.
  • Tarbox Family Office's TherapeuticsMD position peaked at $8K in Q2 2021.
  • 131 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2021.

Based on Tarbox Family Office's 13F filing for Q4 2021, filed 6 Jan 2022.